Zachary W. Reichenbach, Ph.D.
Affiliations: | 2015 | Physiology | Temple University, Philadelphia, PA, United States |
Area:
Neuroscience Biology, Immunology, PharmacologyGoogle:
"Zachary Reichenbach"Parents
Sign in to add mentor| Ronald Tuma | grad student | 2015 | Temple University | |
| (Modulation of the endogenous cannabinoid system to attenuate inflammation in central nervous system injury.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Reichenbach ZW, DiMattio K, Rajakaruna S, et al. (2022) Modulation of Morphine Analgesia, Antinociceptive Tolerance, and Mu-Opioid Receptor Binding by the Cannabinoid CB2 Receptor Agonist O-1966. Frontiers in Pharmacology. 13: 803331 |
| Ward SJ, Castelli F, Reichenbach ZW, et al. (2017) Surprising outcomes in cannabinoid CB1/CB2 receptor double knockout mice in two models of ischemia. Life Sciences |
| Reichenbach ZW, Li H, Ward SJ, et al. (2016) The CB1 Antagonist, SR141716A, Is Protective in Permanent Photothrombotic Cerebral Ischemia. Neuroscience Letters |
| Reichenbach ZW, Li H, Gaughan JP, et al. (2015) IV and IP administration of rhodamine in visualization of WBC-BBB interactions in cerebral vessels. Microscopy Research and Technique |
| Neelakantan H, Tallarida RJ, Reichenbach ZW, et al. (2015) Distinct interactions of cannabidiol and morphine in three nociceptive behavioral models in mice. Behavioural Pharmacology. 26: 304-14 |
| Wu W, Li H, Navaneetham D, et al. (2012) The kunitz protease inhibitor domain of protease nexin-2 inhibits factor XIa and murine carotid artery and middle cerebral artery thrombosis. Blood. 120: 671-7 |